BI
RCUS icon

BVF Inc’s Arcus Biosciences RCUS Stock Holding History

BVF Inc’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,303,520
Closed -$47.6M – 77
2022
Q4 		$47.6M Sell
2,303,520
-413,500
-15% -$11.4M 2.01% 16
2022
Q3 		$71.1M Sell
2,717,020
-1,243,928
-31% -$32.9M 2.94% 10
2022
Q2 		$100M Hold
3,960,948
– – 4.85% 3
2022
Q1 		$125M Buy
3,960,948
+562,881
+17% +$18.9M 5% 4
2021
Q4 		$138M Buy
3,398,067
+168,245
+5% +$6.53M 4.99% 3
2021
Q3 		$113M Buy
3,229,822
+432,000
+15% +$13.4M 4.39% 4
2021
Q2 		$76.8M Buy
2,797,822
+921,700
+49% +$26.3M 2.88% 11
2021
Q1 		$52.7M Sell
1,876,122
-876,100
-32% -$30.5M 1.98% 16
2020
Q4 		$71.4M Buy
2,752,222
+155,000
+6% +$3.75M 2.81% 11
2020
Q3 		$44.5M Buy
2,597,222
+714,500
+38% +$16M 2.42% 15
2020
Q2 		$46.6M Buy
1,882,722
+1,844,148
+4,781% +$49.8M 2.87% 12
2020
Q1 		$535K Sell
38,574
-3,540,449
-99% -$44M 0.05% 55
2019
Q4 		$36.1M Hold
3,579,023
– – 2.74% 12
2019
Q3 		$32.6M Buy
3,579,023
+43,800
+1% +$352K 3.42% 8
2019
Q2 		$28.1M Buy
3,535,223
+725,000
+26% +$7.26M 3.07% 9
2019
Q1 		$35.1M Buy
2,810,223
+398,600
+17% +$4.33M 3.93% 7
2018
Q4 		$26M Buy
2,411,623
+1,352,783
+128% +$15.8M 3.39% 8
2018
Q3 		$14.8M Buy
1,058,840
+99,000
+10% +$1.26M 1.3% 29
2018
Q2 		$11.7M Sell
959,840
-309,948
-24% -$4.86M 1.15% 26
2018
Q1 		$19.6M Buy
+1,269,788
New +$21.2M 1.99% 19

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BVF Inc's RCUS Position: Q1 2023 in Review

BVF Inc sold out of Arcus Biosciences (RCUS) in Q1 2023, closing a stake of 2,303,520 shares — an estimated $47.6M sold.

BVF Inc first reported a position in RCUS in Q1 2018 and held it in 20 quarters. The position peaked at $138M in Q4 2021. 179 funds tracked by Wall St. Rank hold RCUS as of Q1 2023.

  • BVF Inc reported no remaining Arcus Biosciences position as of Q1 2023 after selling out during the quarter.
  • BVF Inc sold 2,303,520 Arcus Biosciences shares in Q1 2023, an estimated $47.6M.
  • BVF Inc first reported a position in Arcus Biosciences in Q1 2018 and held it in 20 quarters.
  • BVF Inc's Arcus Biosciences position peaked at $138M in Q4 2021.
  • 179 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2023.

Based on BVF Inc's 13F filing for Q1 2023, filed 15 May 2023.